219 related articles for article (PubMed ID: 16271102)
1. Bicarbonate inhibits the growth of Staphylococcus epidermidis in platelet concentrates by lowering the level of non-transferrin-bound iron.
Matinaho S; Karhumäki P; Parkkinen J
Transfusion; 2005 Nov; 45(11):1768-73. PubMed ID: 16271102
[TBL] [Abstract][Full Text] [Related]
2. Non-transferrin-bound iron in platelet concentrates promotes the growth of Staphylococcus epidermidis.
Matinaho S; Parkkinen J
Transfusion; 2005 Jun; 45(6):927-33. PubMed ID: 15934991
[TBL] [Abstract][Full Text] [Related]
3. pH value promotes growth of Staphylococcus epidermidis in platelet concentrates.
Störmer M; Kleesiek K; Dreier J
Transfusion; 2008 May; 48(5):836-46. PubMed ID: 18298602
[TBL] [Abstract][Full Text] [Related]
4. Effect of platelet additive solution on bacterial dynamics and their influence on platelet quality in stored platelet concentrates.
Greco CA; Zhang JG; Kalab M; Yi QL; Ramirez-Arcos SM; Gyongyossy-Issa MI
Transfusion; 2010 Nov; 50(11):2344-52. PubMed ID: 20553431
[TBL] [Abstract][Full Text] [Related]
5. Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucrose.
Barton Pai A; Pai MP; Depczynski J; McQuade CR; Mercier RC
Am J Nephrol; 2006; 26(3):304-9. PubMed ID: 16809897
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence assay of non-transferrin-bound iron in thalassemic sera using bacterial siderophore.
Sharma M; Saxena R; Gohil NK
Anal Biochem; 2009 Nov; 394(2):186-91. PubMed ID: 19632191
[TBL] [Abstract][Full Text] [Related]
7. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin.
Gosriwatana I; Loreal O; Lu S; Brissot P; Porter J; Hider RC
Anal Biochem; 1999 Sep; 273(2):212-20. PubMed ID: 10469492
[TBL] [Abstract][Full Text] [Related]
8. Ferrophilic characteristics of Vibrio vulnificus and potential usefulness of iron chelation therapy.
Kim CM; Park RY; Choi MH; Sun HY; Shin SH
J Infect Dis; 2007 Jan; 195(1):90-8. PubMed ID: 17152012
[TBL] [Abstract][Full Text] [Related]
9. Myocardial release of non-transferrin-bound iron during cardio-pulmonary bypass surgery.
Ambrus CM; Lajos TZ; Stadler I; Stadler A; Alfano J; Tulumello JA; Ambrus JL
J Med; 1999; 30(3-4):157-67. PubMed ID: 17312669
[TBL] [Abstract][Full Text] [Related]
10. Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients.
Breuer W; Ghoti H; Shattat A; Goldfarb A; Koren A; Levin C; Rachmilewitz E; Cabantchik ZI
Am J Hematol; 2012 Jan; 87(1):55-61. PubMed ID: 22125177
[TBL] [Abstract][Full Text] [Related]
11. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
Cardigan R; Sutherland J; Garwood M; Bashir S; Turner C; Smith K; Hancock V; Wiltshire M; Pergande C; Williamson LM
Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus epidermidis forms biofilms under simulated platelet storage conditions.
Greco C; Martincic I; Gusinjac A; Kalab M; Yang AF; Ramírez-Arcos S
Transfusion; 2007 Jul; 47(7):1143-53. PubMed ID: 17581148
[TBL] [Abstract][Full Text] [Related]
13. Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality.
van der Meer PF; Pietersz RN; Reesink HW
Transfusion; 2004 Aug; 44(8):1204-11. PubMed ID: 15265125
[TBL] [Abstract][Full Text] [Related]
14. Removal of non-transferrin-bound iron from blood with iron overload using a device with immobilized desferrioxamine.
Ambrus CM; Stadler I; Toumbis CA; Stadler A; Anthone S; Anthone R; DeAlarcon P; Deshpande G; Conway J; Vladutiu AO; Ambrus JL
J Med; 1999; 30(3-4):211-24. PubMed ID: 17312675
[TBL] [Abstract][Full Text] [Related]
15. Dependence of Staphylococcus epidermidis on non-transferrin-bound iron for growth.
Matinaho S; von Bonsdorff L; Rouhiainen A; Lönnroth M; Parkkinen J
FEMS Microbiol Lett; 2001 Mar; 196(2):177-82. PubMed ID: 11267776
[TBL] [Abstract][Full Text] [Related]
16. Improved quantification for non-transferrin-bound iron measurement using high-performance liquid chromatography by reducing iron contamination.
Sasaki K; Ikuta K; Tanaka H; Ohtake T; Torimoto Y; Fujiya M; Kohgo Y
Mol Med Rep; 2011; 4(5):913-8. PubMed ID: 21720715
[TBL] [Abstract][Full Text] [Related]
17. Platelet additive solutions: a future perspective.
van der Meer PF
Transfus Clin Biol; 2007 Dec; 14(6):522-5. PubMed ID: 18420439
[TBL] [Abstract][Full Text] [Related]
18. Six years' experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results.
Larsen CP; Ezligini F; Hermansen NO; Kjeldsen-Kragh J
Vox Sang; 2005 Feb; 88(2):93-7. PubMed ID: 15720606
[TBL] [Abstract][Full Text] [Related]
19. Bacterial growth kinetics in ACD-A apheresis platelets: comparison of plasma and PAS III storage.
Dumont LJ; Wood TA; Housman M; Herschel L; Brantigan B; Heber C; Houghton J
Transfusion; 2011 May; 51(5):1079-85. PubMed ID: 21077911
[TBL] [Abstract][Full Text] [Related]
20. Detection of bacteria in platelet concentrates prepared from spiked single donations using cultural and molecular genetic methods.
Störmer M; Cassens U; Kleesiek K; Dreier J
Transfus Med; 2007 Feb; 17(1):61-70. PubMed ID: 17266705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
